Cargando…
Potential Immune Biomarkers in Diagnosis and Clinical Management for Systemic Lupus Erythematosus
BACKGROUND: There is still no reliable, specific biomarker for precision diagnosis and clinical monitoring of systemic lupus erythematosus. The aim of this study was to investigate the importance of the determination of immunofenotypic profiles (T, B lymphocytes and NK cells) and serum cytokine conc...
Autores principales: | Zecevic, Lamija, Karamehic, Jasenko, Coric, Jozo, Stubljar, David, Avdagic, Nesina, Selmanovic, Kenan, Jukic, Tomislav, Savic, Sinisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294097/ https://www.ncbi.nlm.nih.gov/pubmed/30581353 http://dx.doi.org/10.1515/jomb-2017-0048 |
Ejemplares similares
-
Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes
por: Aganovic-Musinovic, Izeta, et al.
Publicado: (2012) -
Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
por: Karamehic, Jasenko, et al.
Publicado: (2014) -
ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016) -
Financial Aspects and the Future of the Pharmaceutical Industry in the United States of America
por: Karamehic, Jasenko, et al.
Publicado: (2013) -
The Relation of Erythropoietin Towards Hemoglobin and Hematocrit in Varying Degrees of Renal Insufficiency
por: Panjeta, Mirsad, et al.
Publicado: (2015)